Literature DB >> 32309292

The Presence of Renal IgG Deposits in Necrotizing Crescentic Glomerulonephritis Associated with ANCA Is Not Related to Worse Renal Clinical Outcomes.

Caroline Dudreuilh1, Fadi Fakhouri2, Cécile Vigneau3, Jean-François Augusto4, Marie-Christine Machet5, Nolwenn Rabot1, Marion Chapal2, Vianney Charpy2, Christelle Barbet1, Matthias Büchler1, Jean-Michel Halimi1, Philippe Gatault1.   

Abstract

INTRODUCTION: Classical pauci-immune necrotizing crescentic glomerulonephritis (CGN) associated with antineutrophil cytoplasmic autoantibodies (ANCA) is characterized by the absence of renal immunoglobulin (Ig) deposits. However, IgG deposits can sometimes be present. We wanted to assess whether necrotizing CGN with IgG deposits is associated with a more severe presentation and outcome than necrotizing CGN without IgG deposits.
METHODS: Between November 2008 and August 2013, we retrospectively identified 158 patients from four centers who had necrotizing CGN due to primary ANCA-associated systemic vasculitis. Glomerular IgG deposits were found in 18 (11%) patients (group 1). For each patient in group 1, we selected 2 patients with classical pauci-immune necrotizing CGN with the nearest date of diagnosis in the same center (group 2, n = 36). We assessed clinical, biological, and pathological characteristics in both groups.
RESULTS: Baseline characteristics were similar in both groups, and most patients had ANCA-associated vasculitis with antibodies to myeloperoxidase (74%). Deposits displayed moderate to strong staining in 9 patients. As compared with group 2, group 1 exhibited a higher frequency of interstitial fibrosis/tubular atrophy lesions (p = 0.024) and lower frequency of acute tubular necrosis (p = 0.046). Nevertheless, after a mean follow-up of 30 and 26 months for group 1 and group 2, respectively, IgG deposits did not affect the renal prognosis or probability of relapse. Finally, the groups did not differ in renal or patient survival.
CONCLUSIONS: IgG deposits, detected in 11% of patients with ANCA-associated necrotizing CGN, did not affect renal or patient outcomes.
Copyright © 2019 by S. Karger AG, Basel.

Entities:  

Keywords:  Antineutrophil cytoplasmic antibodies; Glomerulonephritis; Immunoglobulin G; Kidney; Systemic vasculitis

Year:  2019        PMID: 32309292      PMCID: PMC7154286          DOI: 10.1159/000503969

Source DB:  PubMed          Journal:  Kidney Dis (Basel)        ISSN: 2296-9357


  26 in total

1.  ANCA-associated crescentic glomerulonephritis with immune complex deposits.

Authors:  Keiichi Sumida; Yoshifumi Ubara; Kazufumi Nomura; Junichi Hoshino; Tatsuya Suwabe; Rikako Hiramatsu; Eiko Hasegawa; Noriko Hayami; Masayuki Yamanouchi; Naoki Sawa; Fumi Takemoto; Kenmei Takaichi; Kenichi Ohashi
Journal:  Clin Nephrol       Date:  2012-06       Impact factor: 0.975

2.  Prospective study of radioimmunoassay for antibodies against neutrophil cytoplasm in diagnosis of systemic vasculitis.

Authors:  C O Savage; C G Winearls; S Jones; P D Marshall; C M Lockwood
Journal:  Lancet       Date:  1987-06-20       Impact factor: 79.321

3.  Histopathologic classification of ANCA-associated glomerulonephritis.

Authors:  Annelies E Berden; Franco Ferrario; E Christiaan Hagen; David R Jayne; J Charles Jennette; Kensuke Joh; Irmgard Neumann; Laure-Hélène Noël; Charles D Pusey; Rüdiger Waldherr; Jan A Bruijn; Ingeborg M Bajema
Journal:  J Am Soc Nephrol       Date:  2010-07-08       Impact factor: 10.121

4.  Glomerular immune deposits are associated with increased proteinuria in patients with ANCA-associated crescentic nephritis.

Authors:  Irmgard Neumann; Heinz Regele; Renate Kain; Rainer Birck; Franz Thomas Meisl
Journal:  Nephrol Dial Transplant       Date:  2003-03       Impact factor: 5.992

5.  Mycophenolate mofetil vs azathioprine for remission maintenance in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized controlled trial.

Authors:  Thomas F Hiemstra; Michael Walsh; Alfred Mahr; Caroline O Savage; Kirsten de Groot; Lorraine Harper; Thomas Hauser; Irmgard Neumann; Vladimir Tesar; Karl-Martin Wissing; Christian Pagnoux; Wilhelm Schmitt; David R W Jayne
Journal:  JAMA       Date:  2010-11-08       Impact factor: 56.272

6.  Long-term follow-up of patients with severe ANCA-associated vasculitis comparing plasma exchange to intravenous methylprednisolone treatment is unclear.

Authors:  Michael Walsh; Alina Casian; Oliver Flossmann; Kerstin Westman; Peter Höglund; Charles Pusey; David R W Jayne
Journal:  Kidney Int       Date:  2013-04-24       Impact factor: 10.612

7.  Immune complex deposits in ANCA-associated crescentic glomerulonephritis: a study of 126 cases.

Authors:  Mark Haas; Joseph A Eustace
Journal:  Kidney Int       Date:  2004-06       Impact factor: 10.612

8.  Renal survival and prognostic factors in patients with PR3-ANCA associated vasculitis with renal involvement.

Authors:  Marjan C Slot; Jan Willem Cohen Tervaert; Casper F M Franssen; Coen A Stegeman
Journal:  Kidney Int       Date:  2003-02       Impact factor: 10.612

9.  Damage in the anca-associated vasculitides: long-term data from the European vasculitis study group (EUVAS) therapeutic trials.

Authors:  Joanna Robson; Helen Doll; Ravi Suppiah; Oliver Flossmann; Lorraine Harper; Peter Höglund; David Jayne; Alfred Mahr; Kerstin Westman; Raashid Luqmani
Journal:  Ann Rheum Dis       Date:  2013-11-15       Impact factor: 19.103

10.  Prediction of ESRD in pauci-immune necrotizing glomerulonephritis: quantitative histomorphometric assessment and serum creatinine.

Authors:  Clara J Day; Alec J Howie; Peter Nightingale; Shazia Shabir; Dwomoa Adu; Caroline O Savage; Peter Hewins
Journal:  Am J Kidney Dis       Date:  2009-12-31       Impact factor: 8.860

View more
  2 in total

1.  Glomerular Immune Deposition in MPO-ANCA Associated Glomerulonephritis Is Associated With Poor Renal Survival.

Authors:  Wei Lin; Chanjuan Shen; Yong Zhong; Joshua D Ooi; Peter Eggenhuizen; Ya-Ou Zhou; Hui Luo; Jing Huang; Jin-Biao Chen; Ting Wu; Ting Meng; Zhou Xiao; Xiang Ao; Weisheng Peng; Rong Tang; Hongling Yin; Xiangcheng Xiao; Qiaoling Zhou; Ping Xiao
Journal:  Front Immunol       Date:  2021-03-25       Impact factor: 7.561

Review 2.  Emerging Biomarkers for Early Detection of Chronic Kidney Disease.

Authors:  Maja Mizdrak; Marko Kumrić; Tina Tičinović Kurir; Joško Božić
Journal:  J Pers Med       Date:  2022-03-31
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.